Podcasts about genes

Send us comments, suggestions and ideas here! In this week's episode we continue following the bread-crumb trail of clues within the recently released tranche of Epstein files that elucidate both Epstein's and his friend's private thoughts as well as evil, science-fiction-worthy master plan that Epstein seems to have been working toward prior to his death (or disappearing into hiding, if you believe that.) While many others are digging into specific crimes, we're going to focus on underlying philosophy and motive. In the first half of the show we discuss Epstein's ongoing obsession with eugenics, buying babies, how the elites really feel about minorities (you can probably guess) and what it all has to do with determining psychic ability. In the second half of the show we explore the five stage classification system used by Gino Yu to determine somebody's psychic level, Epstein's strategy for stealing Rupert Sheldrake's work on psychic phenomena when bribery and seduction wouldn't work, finding the overlap between humans and plans and finally, how all of Epstein's efforts seems have culminated in setting up charities that turn into government mandates when an emergency decides to happen. Buckle up, good luck, thank you and enjoy the show! In this week's episode we discuss:-Epstein's Fascination With Eugenics -Buying Babies-Joscha Bach's Theory of Racial Hierarchies -Epstein's thoughts about music?-Tibetan Buddhist Monk Visualization Study In the extended episode available at www.patreon.com/TheWholeRabbit we go further down the rabbit hole to discuss:-Cybernetics and Consilience-The Science Behind Blue Eyes -Noam Chomsky -Gino Yu's Psychic Classification and Recruitment System-Stealing Morphic Fields from Rupert Sheldrake -Giving Plants Alzheimer's-The Exploitation of Africa-The Charity Pipeline This week's episode was researched by Heka Astra whose notes are in purple, Luke whose notes are in Red with additional commentary by Mari Sama and Tim Hacker. Where to find The Whole Rabbit:Spotify: https://open.spotify.com/show/0AnJZhmPzaby04afmEWOAVInstagram: https://www.instagram.com/the_whole_rabbitTwitter: https://twitter.com/1WholeRabbitOrder Stickers: https://www.stickermule.com/thewholerabbitOther Merchandise: https://thewholerabbit.myspreadshop.com/Music By Spirit Travel Plaza:https://open.spotify.com/artist/30dW3WB1sYofnow7y3V0YoThis week's episode was researched by Luke Madrid, Heka Astra with commentaries and quotes provided by Tim Hacker and Mari Sama.SourcesSee Patreon for Sources - too exhaustive to list here. Support the show

In this episode, I sit down with behavioral geneticist and professor Dr. Kathryn Paige Harden to talk about what behavioral genetics can actually tell us about our kids—and what it can't. We unpack the reality of psychiatric risk, family history, and the limits of control, and why genes are not destiny. We discuss how thousands of tiny genetic differences shape mental health, why diagnoses are messier than we think, and how warmth and firm boundaries still matter more than any “magic bullet.”I WROTE MY FIRST BOOK! Order your copy of The Five Principles of Parenting: Your Essential Guide to Raising Good Humans Here: https://bit.ly/3rMLMsLSubscribe to my free newsletter for parenting tips delivered straight to your inbox: https://dralizapressman.substack.com/Follow me on Instagram for more:@raisinggoodhumanspodcast Sponsors:Ello: Visit ElloProducts.com/CleanStart and use code RGH at checkout for 20% off your first purchaseBrodo: Head to Brodo.com/HUMANS for 20% off your first subscription order and use code HUMANS for an additional $10 offKa'Chava: Go to https://kachava.com and use code HUMANS for 15% off your first orderExperian: Get started with the Experian App now!Fora: Become a Fora Advisor today at Foratravel.com/HUMANSBloom: Go to bloomnu.com with code HUMANS for 20% off your first orderProduced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ayuda a sostener este apostolado. Envía mensaje de WhatsApp al +52 33 2813 6085 diciendo: "Quiero apoyar", y te diremos cómo puedes hacernos llegar tu ayuda. Para descargar los Salmos Penitenciales, ir al siguiente link:https://www.padrejuanrazo.com/articulos/reza-los-salmos-penitenciales Sigue nuestra página web: https://conservandolafe.com/Para recibir aviso de nuevos videos o unirte a la Red de Familias Conservando la Fe, envía mensaje de WhatsApp al +523328136085

Garfield lore and the reality of adversarial thought forms.Sumo's comprehensive guide to understanding, perceiving and combating mythological creatures.Ideas exist even if nobody currently holds them.Memes and genes. People don't have ideas, ideas have people.Numerical PlatonismDemons vs memes, Cognitohazards and non-human incorporeal beings.Containment methods.The anti-meme, self-keeping secrets, what if everyone's already seen Bigfoot ten thousand times.Change blindness, the brain is a filter.The barrier between science and faith, matter and spirit, brain and mind, does not exist.A case study of lethal earworm.A romance of many dimensions.Evidence you are always conscious.The River Styx and the Myth of Er.Identifying gaps in cognition, radical skepticism of one's own knowledge of the world.Defense against memetics is possible although difficult.Olympics talk and games Kavi played as a kid in Canada.Support the showMore Linkswww.MAPSOC.orgFollow Sumo on TwitterAlternate Current RadioMAPSOC back on YouTube Again!Support the Show!Subscribe to the Podcast on GumroadSubscribe to the Podcast on PatreonSubscribe to the Podcast on BuzzsproutSubscribe to the Podcast on SubstackBuy Us a Tibetan Herbal TeaSumo's SubstacksHoly is He Who WrestlesModern Pulp

Perimenopause does not have to be the beginning of decline, but can instead be the start of your strongest chapter! In this inspiring success story, Louise, a leading expert for perimenopausal active women and runners, sits down with Jen, an everyday runner and mom who transformed her health, hormones, and body composition after years of frustration. Jen shares how anxiety, overtraining, fasting, and misinformation left her injured and stuck, despite doing everything she thought was “right.” The turning point came when she learned to fuel her body to build beautiful hormones and mitigate symptoms, apply specific targeted strength training, adjust her running, and work with her hormones instead of against them.Listeners will take away a powerful reminder that thriving in perimenopause does not require extreme diets or complicated protocols. Simple yet strategic consistent habits are often the most effective. This episode also highlights how community support, understanding your body's signals, and using whole foods strategically can improve energy, reduce inflammation, and restore confidence.If you feel discouraged by changing hormones, stubborn belly fat, being told there is nothing you can do about your genetic predispositions, or frustrating injuries that make you question your future as an active woman, Jen's story shows what is possible with the right approach, support, and mindset.RESOURCESLearn with my free nutrition guide and award-winning Academy to thrive through perimenopause with less stress: https://www.breakingthroughwellness.com/ Take Injury Prevention for Women Runners 30+ or my Female Runners Guide to Support Optimal Ferritin Masterclasses mentioned here.Grab a free monthly goal planning calendar & learn how to use it here.Get $25 off Function's comprehensive labs here or use code LVALENTINE11 Check out FullScript here where you can see curated supplement picks & save 20% off. A small portion of the sale goes back to support BTW.  Thank you!Save 20% off Kion's science-backed products. Code "LOUISE" saves on all future orders: https://www.getkion.com/pages/maximizingHighlights:(0:00) Intro(3:02) Retreat and power of supportive community(6:03) Rethinking running intensity and long-term health(13:05) Jen's journey into running for anxiety(17:37) Midlife wake-up call and quitting alcohol(22:20) Weight gain, injuries, and fasting mistakes(24:30) Severe injury and fear of never running again(27:11) Strength training and SI joint breakthroughs(35:31) Nutrition label awareness and inflammation insights(38:07) Simple fueling framework and sustainable habits(41:06) Bloodwork improvements using food(45:25) Genes, hormones, and personalized health approach(48:00) Biological age improvements and body transformation(51:53) Preview of part twoTune in weekly to "Maximizing Hormones, Physique, and Running Through Perimenopause" for our simple female-specific science-based revolution. Let's unlock our best with less stress!I'd love to connect! Email

Wondering why your child struggles with focus, mood, or emotional outbursts? Could a gene be amplifying ADHD, anxiety, and dysregulation, increasing stress sensitivity? Dr. Roseann Capanna-Hodge, creator of Regulation First Parenting™, shows parents how to decode behavior and calm the brain effectively.If you've tried everything and your child still melts down, struggles to focus, or seems stuck in fight-or-flight, you're not failing. You're not alone. In this episode, I dive into how a gene could be amplifying ADHD, anxiety, and dysregulation and, most importantly, what you can do to calm the brain and create real change.Why does my child seem more reactive than other kids, even with good parenting?When a child's nervous system is already under pressure, genetic factors can lower their stress tolerance. Genes like MTHFR don't cause attention deficit hyperactivity disorder (ADHD), anxiety disorders, or emotional dysregulation—but they can amplify vulnerability when combined with chronic stress, genetic and environmental influences, and other risk factors.This matters because research shows ADHD and related psychiatric disorders have a complex genetic architecture involving multiple genes, gene–environment interactions, and socioeconomic factors.Key takeaways:Genes involved can affect detoxification, inflammation, and neurotransmitters like dopamine and serotoninStress exposure fills the “stress cup” fasterBehavior is communication—not a character flawReal-Life Example: Two kids have the same school day. One recovers quickly. The other melts down for hours. Same environment—different genetic susceptibility, highlighting how genetic and environmental influences shape responses to everyday stress.Could MTHFR really impact ADHD symptoms, anxiety, or emotional regulation?Yes—but not in the scary way social media makes it sound. MTHFR is one of many genetic variations affecting methylation, the process that helps the body clear stress hormones and inflammatory byproducts. When methylation is sluggish, the sympathetic nervous system stays activated longer, making recovery from stress more difficult.Findings suggest kids with ADHD symptom dimensions, obsessive compulsive disorder, anxiety disorders, or major depressive disorder may struggle more with recovery after stress—especially when genetic and socioeconomic interplay, genetic and environmental influences, and other environmental risk factors pile up.What parents often notice:Heightened anxiety & emotional volatilitySlower recovery after meltdownsSensitivity to medications or supplementsThis doesn't change the ADHD diagnosis—but it helps explain why regulation takes more effort in some children, even with supportive parenting and structured routines.If you're tired of walking on eggshells or feeling like nothing works…Get the FREE Regulation Rescue Kit and finally learn what to say and do in

Blood cancers are the fifth most common group of cancers in the UK. But for a small number of people, the condition may have an inherited genetic cause.  In this episode of Behind the Genes, we explore the role of genetics in blood cancer, and what an inherited risk means for patients and their families. Our guests explain what blood cancer is, how inherited factors can increase risk, and why multidisciplinary teamwork is key to supporting families. They also look ahead to future advances, from whole genome sequencing to prevention trials.  Our host Amanda Pichini, Clinical Director at Genomics England, is joined by:  Dr Katie Snape, Principal Clinician at Genomics England and Consultant Cancer Geneticist  Bev Speight, Principal Genetic Counsellor Dr Sarah Westbury, Consultant Haematologist “By doing whole genome sequencing we get all of the information about all of the changes that might have happened, we know whether any are inherited, but importantly, we're certain of the ones that have just occurred in the cancer cells and can help guide us with their treatment.”  You can download the transcript or read it below. Amanda: Hello, and welcome to Behind the Genes.  Sarah: When we think about blood cancers, it's a whole range of different conditions and when you talk to patients who are affected with blood cancers or are living with them, their experiences are often really different from one another, depending in part on what kind of blood cancer they have.  We also know that blood cancers affect not just the cell numbers but also the way that those cells function, and so the range of symptoms that people can get is really variable.  Amanda: I am your host, Amanda Pichini, clinical director at Genomics England and genetic counsellor.  Today I'll be joined by Dr Katie Snape, principal clinician at Genomics England and a consultant cancer geneticist in London, Bev Speight, a principal genetic counsellor in Cambridge, and Dr Sarah Westbury, and haematologist from Bristol.  They'll be talking about blood cancers and the inherited factors that increase blood cancer risk.  If you enjoy this episode, we'd love your support, so please subscribe, rate and share on your favourite podcast app.  Let's get started.  Thanks to everyone for joining us today on this podcast, we're delighted to have so many experts in the room to talk to us about blood cancer.  I'd love to start with each of you introducing yourself and telling us and the listeners a little bit about your role, so, Sarah, could we start with you?  Sarah: Sure.  It's great to be here.  My name's Sarah Westbury, and I'm a consultant haematologist who works down in Bristol.  And my interest in this area is I'm a diagnostic haematologist so I work in the laboratories here in the hospitals, helping to make a diagnosis of blood cancer for people who are affected with these conditions.  And I also look after patients in clinic who have different forms of blood cancer, but particularly looking after families who have an inherited predisposition to developing blood cancer.  And in the other half of my job, I work as a researcher at the University of Bristol.  And in that part of my job, I'm interested in understanding the genetic basis of how blood counts are controlled and some of the factors that lead to loss of control of those normal blood counts and how the bone marrow functions and works.  Amanda: Thank you.  That's really interesting, we'll be looking forward to hearing more about your experience.  Bev, we'll come to you next.  Bev: Thank you.  Hello everyone, I'm Bev Speight, I'm a genetic counsellor, and I work at Addenbrooke's Hospital in Cambridge.  I work with families with hereditary cancers in the clinical genetic service, and for the last six years or so have been focused on hereditary blood cancers.  So we've been helping our haematologists across the region to do genetic tests and interpret the results, and then in my clinic seeing some of the onward referrals that come to clinical genetics after a hereditary cause for blood cancer is found.  I'm also part of the Council for the UK Cancer Genetics Group.  Amanda: Thank you, Bev.  And Katie, over to you.  Katie: Hello, I'm Katie Snape.  I'm a genetics doctor and I am a specialist in inherited cancer.  So we look after anyone who might have an increased chance of developing cancer in their lifetime due to genetic factors.  I am the chair of the UK Cancer Genetics Group, so that's a national organisation to try and improve the quality of care and care pathways for people with inherited cancer risk in the UK.  And I have a special interest in inherited blood cancers through my work at King's College Hospital, I work in the haematology medicine service there seeing individuals who might have or have been diagnosed as having an inherited component to their blood cancers.  So it's great to be here.  Amanda: Excellent, thank you for those introductions.  I'd like to then dive right in and understand a little bit more about blood cancers.  So, Sarah, could you tell us a little bit more about what blood cancer is?  Sarah: Yes, sure.  The term blood cancer is used to describe a whole range of different kinds of cancer, all of which affect some part of the blood or sometimes parts of the immune system that kind of gets represented as part of the blood.  So it's really describing a big group of conditions rather than one single kind of condition or entity itself.  But like any form of cancer, we understand blood cancers as being conditions where because cells as part of the blood system are rapidly dividing and normally doing so under really well controlled circumstances to produce just the right balance of blood cells and just the right number of those cells.  In a cancer affecting those cells, we see that that loss of control results in either too many of one type of blood cell being produced or too few, or that balance being lost.  And like any form of cancer, this is because of genetic changes that happen in individual cells that then go on to grow in a way that is not controlled and well regulated.    And because when we talk about blood cancer we're talking about such a wide range of different kinds of cancer affecting different cells within that blood system, there's a really wide range of different conditions.  From conditions that we might think of as being like a form of acute leukaemia, so something that produces often symptoms and signs in patients very quickly and they can often feel quite unwell quite soon and then get picked up with having this condition because they present feeling unwell.  All the way to chronic and slow growing cancers that can be found completely by chance and serendipity when blood tests are done for other reasons.  So when we think about blood cancers, it's a whole range of different conditions.  And when you talk to patients who are affected with blood cancers or are living with them, their experiences are often really different from one another, depending in part on what kind of blood cancer they have.  We also know that blood cancers affect not just the cell numbers, but also the way that those cells function.  And so the range of symptoms that people can get is really variable, again depending on which of the blood cells are really affected by that.  And it may be that during the course of some of the conversations we have today in this podcast, we'll perhaps focus on particular kinds of blood cancer.  But like any cancer, it's that disruption of the normal growth and development of cells that means that the number and function of those blood cells has been disrupted in some way.  Amanda: Thank you so much for explaining that, Sarah, that's really helpful.  In terms of across the range of blood cancers, is that something that people can get at any age, and how common is it?  Sarah: It does depend, as we were sort of talking about that really wide range of different disorders that make up that group of blood cancers.  And individually each of those blood cancers is reasonably uncommon compared to cancers that we might typically think of, like breast cancer or colon cancer.  But actually, if you group blood cancers together, they make up quite a sizeable proportion, and they're actually as a group the fifth most common form of cancer that's diagnosed in people in the UK.  In adults in particular we think that perhaps people diagnosed with leukaemia would make up about 3% of the new diagnosis of cancer made in any year.  Amanda: So coming to you, Bev, when we talk about inherited blood cancers, what are the differences between those and blood cancers more generally?    Bev: So at point of diagnosis, it may not be obvious that somebody with a new blood cancer diagnosis is one of the minority of people in that big group as Sarah has described, who has an inherited cause.  So it may not be immediately obvious.  However, in the last few years certainly, it's become more and more routine to do quite broad genetic testing.  Often on a bone marrow sample or blood, because that is done looking for genetic changes, which are part of all cancer and we find within cancer cells, that can help with treatment planning.  It can also find that there is an inherited cause to that new blood cancer diagnosis.  Sometimes that might not be clear cut, sometimes that might be inferred from the genetic tests that are done on the blood or the bone marrow. And the proportion of blood cancers in that huge group which do have an inherited cause is fairly small, the actual proportion will depend a bit on the age of the patient and the specific subtype of blood cancer.  Amanda: Okay, and could you talk us through how some of those inherited genetic factors can increase the chance of a person developing blood cancer, how does that work?  Bev: Yes, so if we know that there is an inherited cause for blood cancer, then what we mean by that most of the time is that a change in a single gene has been found.  And that there is enough research evidence and enough known about that specific change in that gene to say to the person who's been diagnosed, there is at least in part or perhaps a full explanation for why that blood cancer has developed and this could be shared in the family.  So at that point it's information that not only has implications for the person in treatment, but also their relatives.  Depending on what sort of gene alteration it is and which gene it's found in, there are different inheritance patterns, and that changes the sorts of information that we give about risks for relatives.  So for lots of the genetic tests that detect an inherited cause in adults when they're diagnosed, that's most often what we would call an autosomal dominant inheritance pattern.  Essentially that means you only need to have one gene alteration which is in that person's normal non-cancerous DNA inherited from a parent and can be passed onto a child.  And for people in the family who have inherited this one genetic change, then they are likely to be at increased risk of developing blood cancer.  Sometimes with particularly the children's blood cancers, if an inherited cause is found, it can be a different pattern, which we call autosomal recessive.  And that's where two gene changes are found and one has been inherited from each parent.  So parents might be what we call carriers and have one each just by chance, both have been passed onto a child who has developed blood cancer either in childhood or possibly later on, and that's the pattern we call autosomal recessive.  There are other inheritance patterns too.  The third one that we come across being X-linked, and so that has a gender component.  That's where there's a change on the X chromosome, women have two X's, and men have one X and one Y.  So sometimes with the X-linked conditions we're more likely to see the clinical signs of a condition in boys and men because they've only got that one X chromosome.  But those are less common in the context of talking about hereditary blood cancers.  Amanda: Thank you.  That's really helpful to understand.  So it sounds like you're saying that these forms of blood cancers that are caused by a single gene are relatively rare.  And also by having one of these changes, it's not a given that that person will develop a blood cancer, but it makes them more likely, and how likely that is might depend on the inheritance pattern or the type of condition.  Bev: That's right.  So what we're saying is it can give either part of full explanation for the blood cancer diagnosis, and it could confer a risk to family members, but that doesn't mean they definitely will develop it.  We're talking about an increased risk compared to the population risk.  Amanda: Right.  I can imagine for those families to some extent it might be helpful to know the underlying reason why they had that blood cancer, but again, that's just a small proportion.  So, Katie, could I come to you next?  What about the rest of all the blood cancers, how do they occur?  Katie: Yes, thanks, Amanda.  So most blood cancers will occur just by chance.  We also know that there are some environmental factors that can increase the risk of blood cancers, so, for example, serious radiation exposure, something like that.  What Bev has described is where there is this sort of quite rare condition where there is a kind of single gene that's really important for the blood cells in terms of keeping those control mechanisms that Sarah described.  And that's not working properly, which has increased the risk of a blood cancer.  But we also sometimes see some families where there is more blood cancer, or the same type of blood cancer in that family than we might expect by chance.  We think that's probably not due to a single high risk genetic factor, but might be due to kind of multiple lower risk genetic factors that are sort of shared by close family members and can add up together to increase the risk a little bit.  And we call that familial risk or polygenic risk.  We don't have a test for that at the moment.  We wouldn't offer usually any extra screening or testing to those families, but we would just suggest obviously family members are aware of any signs of symptoms of blood cancers and seek any advice if they're concerned.  But, you know, the majority of blood cancers are not due to genetic factors, and it's sort of environmental or chance or bad luck. Amanda: Okay, so it's clear that obviously blood cancer is almost an oversimplification, within that category there's so many different types, so many ways that it could happen in a person.  So, Bev, if we're dealing with that type of blood cancer that is inherited or has some heritability, can you tell us more about what that means for the family?  What kind of impacts do you see that having for them?  Bev: Yes, of course.  So clearly this is another layer of information that's often coming at a family during a time where somebody is often recently diagnosed with blood cancer of one sort or another and is having to take in a lot of information about treatment and all of the uncertainty and anxiety that goes with that.  So for this minority of patients and families where there is new information about an inherited cause, that needs conveying in a timely but sensitive way, bearing in mind what else is happening.  And for some people it can come as a major shock and really an additional burden at that time.  I think the reaction to that will of course depend on lots of factors.  And what we also see is that this question about a new cancer diagnosis of any sort, including blood cancers, can generate the question in people's mind, particularly if they've got children, about does this change the risk for relatives?  So sometimes this new information that, actually, there is an inherited cause is an answer to a question that families have already got.  And that might be because of what Katie's described as familial clustering, there might already have been this known history in the family. So sometimes this information can feed into that and actually be quite a helpful answer.  But it's quite normal for families to feel quite mixed about this and for different family members to have a different approach to it.  When there's the offer of what we would call predictive testing, if we found a change in a single gene in somebody with blood cancer which we're saying is a hereditary cause for that, that might open the door for relatives to access predictive testing.  I.e., the opportunity to discuss and possibly take up a genetic test for themselves when they haven't had cancer themselves, but there's an opportunity to try and quantify whether or not they're at increased risk.  We know in families the uptake of those kinds of tests is different, and a lot of it is to do with timing and the way people respond to this in families might depend on their response to the cancer diagnosis in their relative, and of course what else is going on in their life at the time.  This aspect for the family is where clinical genetic services come in, because these initial tests in the person with blood cancer are done in their haematology/oncology setting, and normally the results about an inherited cause has been found are conveyed through that service.  That's when a referral to clinical genetics happens.  And in our specialist service we're addressing those additional concerns for the family which arise because of this diagnosis. Amanda: Thanks, Bev, for explaining that.  Sarah, coming back to you.  Could you tell me then if someone has an inherited blood cancer does it also change the way that the patient is treated? Sarah: Well, it certainly can do, and again, it does depend a little bit on the specific circumstances of that particular person and the form of inherited blood cancer predisposition that they have.  But certainly if we think about treatment as a whole, then for a lot of people it does affect the way that we might recommend treatments or look after them and their families.  So, for example, for some patients who have a diagnosis of an inherited form of blood cancer, we know that some treatments might be more or less effective for their particular set of circumstances.  And so that can sometimes influence the specific treatment recommendations that we would make, particularly thinking about, for example, the risks that the cancer might come back again after it's been treated.  Or thinking about whether or not some of the typical drug regimes that might be used might be perhaps more likely to cause them side effects or problems with tolerating that treatment.  So it can certainly make some changes in that respect. For some people, to be fair a minority of people with blood cancers, they may need a stem cell transplant as part of their treatment to hopefully cure them of their blood cancer.  And this as I say is a treatment that's required for a minority of patients as a whole who have a diagnosis of a blood cancer.  But for those people who have got an inherited predisposition and who might be recommended a stem cell transplant as part of their treatment, then knowing about a familial risk for this condition can also be really important.  For making sure that if a family member is being considered as a donor for example that we're being really careful to make sure that we're not choosing a donor that might also be affected by the same underlying blood cancer predisposition.  Because this can obviously cause problems for the person that's receiving the stem cells if it turns out that the person they're receiving them from actually has the same inherited condition as them.  So in that respect knowing about the underlying predisposition and genetic cause for their cancer can be helpful.  But in a more sort of general sense, yes, the other thing that it can have a big difference for is that some of these inherited cancer predispositions and syndromes also have other health conditions associated with them.  So it might be that that genetic diagnosis predisposes somebody not only to a form of blood cancer but to other health conditions as well.  And so actually knowing about that diagnosis can help their haematologist then make sure that they're linked in with the right other medical teams to make sure that those other health conditions are identified if they're present and taken care of.  And then I think really coming back to what Bev has already touched on, there's the sort of bigger picture of just how people are looked after in their own right but also as part of their family unit.  And making sure that they're given the right information and advice about their health, but also thinking about other family members.  And particularly for younger patients who perhaps either are just starting their own families or for whom that's not yet a consideration, making sure that they've got the information to understand what might be relevant for future family members, if that makes sense.  So it's not necessarily true to say that for every individual patient knowing that there's an inherited blood cancer present will necessarily directly affect the way that the treatment is offered.  But you can see that as a part of a bigger picture for a lot of patients, it will make a difference to their care as a whole.  Amanda: And you can really see how the impact is very sort of multigenerational and is going to affect people at all ages and stages of their life, so that's really interesting.  Katie, Bev spoke a little earlier about the fact that there are genetic tests that can help tell us if blood cancer is inherited.  Could you tell us more about what the tests involve, and some of your experience taking families through this?  Katie: There's sort of two main different ways that we might identify somebody has an inherited cause for their blood cancer through testing.  So traditionally what has happened, as Bev and Sarah sort of discussed before, is that when a person is diagnosed with a blood cancer, we either take a sample of their blood or bone marrow.  To try and look at what are the changes within those cells that have driven that cell to become a cancer cell and have driven this blood cancer to develop.  And a lot of the time, as we've said, it's not inherited, it's not genetic, so they're what we call acquired changes, they're changes that have just happened in the bone marrow or to the blood cells that have caused that kind of particular cell to become a cancer cell.  And it's really important that we look at those because that can help both diagnose the blood cancer, it can give us information about how serious that blood cancer might be, and it can also help us guide our treatments and therapies.  And so if we do those testings, they're primarily done within haematology for those sort of diagnostic or prognostic or treatment purposes.  We do sometimes see then a change that looks a bit suspicious that it might be inherited for various reason.  And if we see something that is in the cancer and it looks like there's a potential it could be inherited, we would go on and do a second test.  So usually because we can't do a blood test because the cancer's in the blood, we would take a skin biopsy.  And then we would look and see, well, is this change also present in the skin?  And if it is, then that indicates that that change is in all of the cells of the body, because it's in both the blood cancer and it's in the skin, and therefore it's likely to be inherited.  So that's one thing that we do.  And I think that that can be quite challenging for patients.  Because they go in to have a test for their blood cancer and then suddenly were being told, “Well, actually, we've also found something that might be inherited,” and it is something then that other members of the family might have.  And as Sarah said, potentially that means that even if your relative was offering to be a bone marrow donor for you, they might not be able to if they also carry the same thing.  And so that can be quite tricky just in terms of making sure that we're guiding the patient and their family members through that process.  And then thinking about the work that Genomics England does, particularly with whole genome sequencing, and this is particularly offered for children and young adults in the paediatric setting.  But I think we're also increasingly, as we progress we'll perhaps talk about this a bit, moving towards whole genome sequencing for adult blood cancers more routinely as well, that that is offered as a sort of standard of care.  And what whole genome sequencing is, is it is looking at the entire genetic instruction manual in both the blood cancer cells and in the cells that we're born with, to look at the inherited or germline genome as well.  And the reason that we look at both the cancer cells and the inherited or germline genome is because what we're trying to understand is firstly, are there any inherited changes that have led to the blood cancer developing?  But also, what are the changes that have just occurred in the cancer cells that are going to help us to diagnose and treat that blood cancer?  So by doing whole genome sequencing we get all of the information about all of the changes that might have happened, we know whether any are inherited, but importantly, we're certain of the ones that have just occurred in the cancer cells and can help guide us with their treatment.  And so, again, when we're talking to patients, we have to explain to them that we're going to be looking at their entire genetic information.  And what's interesting about that is it might find things that are not only relevant to blood cancer, but very rarely other findings, incidental findings as well, or we might find things that we don't know about.  But I think certainly that's something that patients often feel very comfortable with having because it gives them the maximum amount of information.  Amanda: Thanks, Katie.  So it really sounds like there's a lot of advancements that are being made in genetic technology which potentially brings a lot of new things for you and Bev as genetic specialists, but also for you, Sarah, as a haematology specialist.  What does that kind of change for you, and I assume it's really important then for you all to be working together as a multidisciplinary team?  Katie: Yes, I mean, I think for clinical genetics, we were not involved in sort of haematology pathways for a really long time, and the haematologists are absolute experts in the genomic factors that drive blood cancers.  And certainly in my practice, it's really only been as the technology advanced that we really started finding more and more of these inherited factors, particularly in the adult setting.  Because I think in the paediatric and childhood setting, the haematologists again have been managing those conditions very well for years.  And I think there's places that we really interface and we really need to work together as a multidisciplinary team, understanding the genetic information, really understanding when something that we've seen in the blood cancer or the bone marrow could be inherited.  Do we need to check that?  What should that pathway look like?  But I think as you've said, a lot of these are actually really quite new conditions, particularly in the adult setting.  And we don't yet 100% know why do some people get blood cancer and some people don't when they have the same inherited factor.  What's the actual risk?  Are there any other factors modifying it?  What makes some people progress to develop a blood cancer and some people not?  And for that we really need to work together to try and gather the data and sort of capture people that have these inherited changes.  And hopefully develop a system and an infrastructure that we can follow it long-term and get a lot of information about long-term outcomes, both for individuals with cancer but also their families.  And also from looking at doing population studies.  Because I think we know that lots of people in the general population might carry some of these inherited changes and never develop a blood cancer as a result of this, certainly ones that seem a bit lower risk.  So we really need to work together to understand all of that.  But I'd be really interested in Sarah's views on that as well.  Sarah: Yes, sure.  So I think, as you say, Katie, haematologists have got a long history of understanding and interpreting genetic findings in the sort of acquired or somatic changes that we know are what occurs in some blood cells to drive the cancer forming in the first place. But this kind of newer integration of that with the germline testing is something that is becoming much more mainstream in haematology now, and I think something that people have had to sort of acquire new skills in this area to interpret that alongside.  I think as you say, that multidisciplinary working, where we're able to benefit from both sides of our expertise and knowledge and put that together is so valuable, particularly in those circumstances where there is some uncertainty.  And I think as a haematologist, one of the things that I really find a benefit both personally and professionally to help me navigate these tricky questions but that I also think patients benefit from is your expertise and ability to have those really quite tricky conversations with people who are not haematology patients, if that makes sense.  So they may be the relatives of patients who have a haematological diagnosis for example.  Who at the moment are entirely well and were just going about their daily business, and they're now told that they may or may not potentially have this inherited predisposition.  And I think that as haematologists, we're very used to dealing with potentially quite poorly patients, potentially quite scared patients who find themselves, you know, the recipient of all this quite difficult information.  But we're not necessarily so skilled and experienced at holding conversations with people who don't yet have that diagnosis.  And I think that that's a really rich area of mutual aid to one another as haematologists and genetic doctors, if that makes sense.  And I think your points about understanding actually the real risks and the nature history, as we would call it, of what happens to people who carry these variants that predispose them to blood cancers is something that we can probably only work out by working together.  And of course, working with the patients and families that are affected by these conditions so that hopefully for both sides in the future we'll be able to give much better advice to patients and their families.  Amanda: So, Bev, from your experience and as a genetic counsellor, what do you feel are the important things that patients and their families should know as they're going through this testing and diagnosis process?  Bev: The things I think families where there is a hereditary cause found should know is that with this new information comes a whole new referral to a dedicated service.  Who want to help patients and their family members at risk to navigate this, to adjust the information, and to make decisions that fit with them, about whether to have testing and the timing of that.  As we already said, where there is a hereditary blood cancer risk, that risk in family members is rarely 100%.  Depending on what the hereditary predisposition is in the family, we may be able to quantify that risk, sometimes we can't always.  And the other thing to know which links to that is that there is growing interest in research in this area.  That will really help us to improve care in terms of, for example, being able to quantify the risk of developing a blood cancer in relatives who are perfectly well that may have inherited these predisposition gene changes.  Or, for example, the other obvious place where we want to make improvements in terms of some sort of evidence-based surveillance for those people who want to find out that they have inherited the genetic change and are at increased risk.  Amanda: Thank you.  And overall there's been a lot I think we've been covering today that's probably going to be very new to many people.  Why do you think it's important to raise public awareness of inherited blood cancers?  Bev: There have been lots of public awareness campaigns about other cancers, as listeners probably can think about, in terms of for women checking their breasts and breast cancer awareness.  And perhaps there's been a bit less of that in general for blood cancers.  As we've already talked about, clinical genetics were not so involved in all of the genetic testing happening in blood cancers.  Because it wasn't so long ago in the history of how we think about inherited cancers in general that our suspicion of inherited causes in leukaemia was much lower than it is now.  So I think that awareness in the public probably will take a bit more effort to bring up.  But clearly public awareness about blood cancers in general, symptom awareness, and the fact that occasionally it can be something that is running in the family, clearly better public awareness of that means that people are empowered to ask the right questions.  And the questions that might already be in some way going through their minds of their haematology doctors or perhaps of their GP, if they've got a family history but are not affected themselves.  Amanda: Wonderful.  So, looking now to the future, Katie, what genomic advancements are we seeing or are we likely to see that could impact on the care of people with an increased genetic risk of blood cancer?  Katie: We touched a little bit, I think that whole genome sequencing is expanding.  And as we can turn that test around and get it back more quickly that might become more commonplace.  And I know Genomics England and the UK Haemato-oncology Network of Excellence have been doing a lot of work in that area.  We are very lucky now we have a national inherited cancer predisposition register that NHS England have set up with the National Disease Registration Service.  So that will enable us to capture individuals that have these sort of rarer but single gene disorders or conditions that increase the chance of developing blood cancers.  And that will enable us to do that sort of longer-term follow-up and get really more information.  We've touched on this already but I think there's really amazing research happening, why do some people develop blood cancers and some people don't, even though everyone carries the same underlying change that increases the risk?  And then I think really importantly, we're seeing now in some conditions, clinical trials of certain medications to see if that can actually prevent people who carry these inherited changes from progressing to developing blood cancers.  So I think all of those things are really exciting and will give us lots more information that we can then help patients and their families, particularly the sort of treatment and trials aspects.  Amanda: And, Sarah, on treatment and trials, how do think genomics might improve the treatment, but also the diagnosis of people with inherited blood cancers in the future?  Sarah: I think, you know, hopefully when we are able to accrue more information about these underlying genetic predispositions and how they actually then affect people's likelihood of developing blood cancer, we'll be able to build on what we have so far to make that just feel much more robust and evidence based.  And it feels like at the moment there are many of us struggling to bring together small threads of evidence that have been accrued in the UK but in other centres around the world that are also interested in understanding this inherited blood cancer risk.  In such a way that we can actually give patients and their families more clear information and advice about what that means to them.  And I think that in terms of the diagnosis of blood cancer, I think this is something that Bev alluded to.  If we could better understand who might benefit for example from having regular screening or monitoring blood tests performed to see whether we can detect an emerging blood cancer.  Versus identifying those people who actually, the chances of them developing a blood cancer are so small that doing those tests is likely to do them more harm than good.  Perhaps by just causing them to be anxious or have other sort of unintended consequences of that kind of testing.  So understanding something more about that natural history, as we've already alluded to, will hopefully improve our ability to go from the diagnosis of the predisposition condition to working out how to then diagnose the blood cancer on the back of that.  And with time, I think as Katie has alluded to, thinking about more specific treatments and more tailored treatments to the individual predisposition condition and the blood cancer.  So whether it's that you're intervening before the blood cancer has developed to try and reduce that happening, or whether it's that you're then treating the blood cancer after it's developed.  Understanding the genetic basis and what it is that causes that transition would be really helpful and I think that is something that will come but will take time.  And I think on a sort of national level what I would really hope to see over time is that we're able to use that improvement in evidence base to then be able to bring together perhaps more defined patient pathways.  So that if you're diagnosed with a particular condition, one of these leukaemia predisposition syndromes or another form of blood cancer predisposition, there's a recognised strategy and set of steps that should be taken for all of those patients.  To make sure that they're getting equity of care and make sure that everything is being done in a way that feels safe, sensible and appropriate across the country.  While still then enabling us to give really personalised treatment to that individual person and what that diagnosis means for them.  But I think until we've gathered more information and more evidence we are just in the process of trying to do that to then bring about those changes.   Amanda: If you enjoyed today's episode, we'd love your support.  So please subscribe, share and rate us on wherever you listen to your podcasts.  I've been your host, Amanda Pichini.  This podcast was produced by Deanna Barac and edited by Bill Griffin at Ventoux Digital.  Thank you for listening. 

[This episode originally aired on May 2, 2023] Today we are exploring four traditional methods or practices we can use to awaken our enlightened genes  •  the first method is cultivating loving kindness, or maitri, which is a key theme in the mahayana; it is connected with the wish that all beings be happy, and that includes you  •  the second method is cultivating compassion, or karuna  •  while loving kindness looks into the nature of happiness, compassion looks into the nature and causes of suffering  •  the third method is cultivating sympathetic joy — a joy based on appreciating others' happiness and accomplishments  •  the fourth method is cultivating equanimity — cultivating an even mind, a grounded mind, a magnanimous mind; we deal with each experience equally with no bias  •  these four methods — kindness, compassion, joy, and equanimity — are gentle, but they are powerful methods for awakening our enlightened genes.

Dr. David Bilstrom is a quadruple board certified medical doctor specializing in autoimmune disorders and gene health. He is board certified in Functional and Regenerative Medicine, Integrative Medicine, Physical Medicine & Rehabilitation, and Medical Acupuncture. His current work focuses on reversing and preventing genetic disorders, primarily in children.    You can follow David's work at: https://drdavidbilstrom.com/ Instagram: https://www.instagram.com/drdavidbilstrom/ YouTube: https://www.youtube.com/@drdavidbilstrom   Want to watch the video? Check out the discussion on YouTube: https://www.youtube.com/@mentalmapspodcast   Mental Maps is brought to you by Arukah Well, a virtual holistic mental health service. To learn more check out www.arukahwell.co or on Instagram @arukahwelllife   keywords: autoimmune disorders, mental health, autism, B vitamins, methylation, epigenetics, gut-brain connection, vitamin D, health, stress management    

Teología | Imágenes verbales del Espíritu Santo | Pr. César González | VNPEM Norte

Un abogado valora la suspensión a Prestianni: "No hay imágenes claras, se le está dando más valor a la palabra de Vinicius y Mbappé"

Las aguas profundas e inexploradas de nuestro planeta han sido siempre fuente de admiración y especulación sobre lo que se oculta en ellas. Las ruinas sumergidas de Dwarka, la estructura submarina en Yonaguni, Japón, o la extraña «ruta» descubierta cerca del Triángulo de las Bermudas, estas y otras estructuras subacuáticas antiguas son un indicio de la existencia de civilizaciones perdidas. Leyendas de ciudades acuáticas gobernadas por dioses, criaturas como el monstruo del Lago Ness o el Kraken, o los frecuentes avistamientos de ovnis… ¿estamos ante indicios que señalan una presencia sobrenatural que acecha en las profundidades submarinas?

Sunday morning 22nd of February, 2026 Genesis chapter4 verses 1 to 7. 2Corinthians chapter 8 verses 1 to 5

Today, I'm delighted to welcome Dr. Yael Joffe, a leading expert in nutrigenomics who speaks internationally at conferences on translating the science of genetics into clinical practice. She holds a PhD in nutrigenomics from the University of Cape Town, where her research focused on the genetics of obesity. I met Yael earlier this fall and decided to invite her on the podcast to explore the growing field of lifestyle genetics. In our conversation today, we dive into the effects of nutrigenomics, nutrition genetics, and SNPs, which she refers to as spelling changes in our DNA. We cover genetic testing in the industry, red flags, DNA health, and her polygenic approach to weight loss resistance. We also discuss both perimenopause and menopause from the perspective of genetics and epigenetics, and the role of insulin signalling and glucose. Yael's insights are deeply informative. Her pioneering work on 36 metabolic pathways and her ability to make complex genetic information accessible and actionable make this a truly invaluable conversation. IN THIS EPISODE, YOU WILL LEARN: Women and gaining weight after starting HRT Neurotransmitters and what they reveal about mood, anxiety, and addiction tendencies Why do certain people break down dopamine and serotonin either too fast or too slowly? How touch and genuine connection can switch on feel-good genes Sunlight, weather, and environment affect genetic expression. What acupuncture and infrared therapies do at the gene level Why hormones are only part of the picture when addressing midlife weight gain How glucose regulation and insulin sensitivity shift through menopause Dr. Joffe's polygenic testing model connects multiple pathways rather than single genes How Yael's approach to genetic testing differs from that of others in the field Bio: YAEL JOFFE, PhD  Yael is globally recognized as a leading expert in nutrigenomics. In 2000, she was part of the team that built the first lifestyle genetics test, and since then has been responsible for creating many others. She is the author of four books: The Power of Genetics, It's Not Just Your Genes, Genes to Plate, and SNP Journal. Yael has been published in multiple peer-reviewed scientific journals, hosts the Power of Genetics podcast, and is a highly regarded speaker in genetics. Yael built the first online nutrigenomics platform for clinician education and has developed and supervised genomics courses around the world. She has trained thousands of healthcare practitioners globally, also teaching at Rutgers University and the Maryland University of Integrative Health. In 2018, Yael founded 3X4 Genetics and now serves as its Chief Science Officer.    Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow)  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Connect with Dr. Yael Joffe 3X4 Genetics Instagram Facebook

Send us comments, suggestions and ideas here! In this week's episode, after nearly seven long years of researching vampires, abstruse occult sciences, shadowy conspiracies and the devil we arrive at the crossroads of chapel perilous where these ideas finally gather at the feet of the civilizational-level arch villain, Jeffery Epstein whose emails reveal a plan so vast, so cartoonish and so evil you threaten your very sanity by even considering it. In the free side of the show we explore Jeffery Epstein's network of scientists that he funded and met with on a regular basis in a prolonged effort to direct their various fields of research toward one goal. In the extended show we read victim statements and explore the supporting evidence that leads to a criminal conspiracy that involves baby farms, AI gods and what exactly the hidden rulers actually believe about God, the Devil and other things you're not even supposed to discuss. But we do anyway. Thank you and enjoy the show! In this week's episode we discuss:Deepak ChopraDIY Gene-hacking and designer babiesTransgenic Sperm Pre-OrdersTranshumanist Funding ProgramsEpstein's Evolutionary Science Team at HarvardVictim Statements about Zorro RanchMassacre of the InnocentsIn the extended, uncensored, politically-incorrect side of the show available at www.patreon.com/TheWholeRabbit we go further down into the Epstein library and discover:What Epstein was doing with so many 23&Me kitsEpstein's obsession with Ashkenazi ancestryVictims StatementsHaplogroup R1b-L2A RARE glimpse behind the curtain of Illuminati racial philosophy thanks to the enthusiastic writing of Joscha Bach (found within the Epstein library). Where to find The Whole Rabbit:Spotify: https://open.spotify.com/show/0AnJZhmPzaby04afmEWOAVInstagram: https://www.instagram.com/the_whole_rabbitTwitter: https://twitter.com/1WholeRabbitOrder Stickers: https://www.stickermule.com/thewholerabbitOther Merchandise: https://thewholerabbit.myspreadshop.com/Music By Spirit Travel Plaza:https://open.spotify.com/artist/30dW3WB1sYofnow7y3V0YoThis week's episode was researched by Luke Madrid, Heka Astra with commentaries and quotes provided by Tim Hacker and Mari Sama.Sources:Times of Israel - Ashkenazi Jews Descend From 350 People Study Finds:https://www.timesofisrael.com/ashkenazi-jews-descend-from-350-people-study-finds/Epstein Fileshttps://www.justice.gov/epstein/files/DataSet%209/EFTA01003966.pdfhttps://www.justice.gov/epstein/files/DataSet%2011/EFTA02625362.pdfhttps://www.justice.gov/epstein/files/DataSet%209/EFTA01019439.pdfhttps://www.justice.gov/epstein/files/DataSet%209/EFTA01019438.pdfSupport the show

Los Originales: 1.Estos diarios revelarán los gustos sexuales de Heffner, incluyendo imágenes desnudas de las mujeres con las que tuvo sexo. Crystal Heffner, su tercera esposa oficial, trata de detener esas publicaciones.

Send a textA drop of blood can change the course of cancer care. Speaking of Women's Health Podcast host Holly Thacker, MD sits down with variant curator Stetson Thacker, PhD to unpack how circulating tumor DNA and tumor‑informed minimal residual disease testing help clinicians see recurrence months before imaging, tailor adjuvant therapy, and track response in real time. Together, they translate complex genomics into clear choices: when a negative MRD result supports de‑escalation, when a persistent positive argues for chemotherapy and how colorectal and breast cancers have led the way in clinical validation.They also cover the guardrails. Not everyone has banked tissue for a tumor‑informed assay, and sensitivity and specificity vary by platform and cancer type. Early multi‑cancer detection tests promise a lot but risk overdiagnosis and anxiety if used without clear indications. The smarter path is matching the right test to the right person at the right time, ideally within guidelines and with an oncologist who can synthesize genomics, imaging, pathology, and patient goals. From colorectal screening shifts to balancing overtreatment in prostate and thyroid cancers, we focus on practical decisions that protect both survival and quality of life.If this deep dive helped you make sense of liquid biopsies and MRD, subscribe, share the episode with someone navigating cancer decisions and leave a review so more listeners can find the show.Support the show

[This episode originally aired on April 25, 2023]  In this episode we will be looking at the obstacles we might encounter in trying to awaken our enlightened genes, as well as situations that support their awakening  • Trungpa Rinpoche called the first obstacle intrinsic slavery: we become slaves to our schemes, to our work, to our possessions  •  the second obstacle is being unaware: having a limited kind of awareness which does not look beyond the superficial level of things  •  the third obstacle says that enlightened genes won't awaken in the midst of evil actions or harmful behavior  •  the fourth obstacle is sleepiness, which is similar to a lack of awareness, but it also has a quality of being dull and drowsy  •  there are two conditions that are conducive to awakening enlightened genes  •  the first is waking up at the right time, which points to creating outer conditions that sustain our practice and cultivate our awakening  •  the second is taking an interest in dharma practice  •  the idea of enlightened genes is that they're there, but they don't always show themselves until the conditions are right, until obstacles are removed. 

For years we have been told that our genes determine our health. If something "runs in the family," many people assume it is only a matter of time before they face the same diagnosis. But what if that belief is only part of the story? In this episode, Dr. Holly Carling and Alicia explore the science of epigenetics and explain how your daily choices influence how your genes express themselves. From nutrition and stress to sleep, mindset, and environment, the body is constantly receiving signals that either support health or contribute to disease. Dr. Carling shares personal stories about changing her own health trajectory despite strong family patterns of obesity, thyroid disorders, and cardiovascular disease. She explains why a genetic predisposition does not mean a guaranteed outcome and how consistent lifestyle changes can shift your future in powerful ways. This episode offers a hopeful reminder that you are not a victim of your genetics. With intentional choices, you can influence how your body functions and support long-term health and vitality. In this episode: Why genes are not a fixed blueprint for your future The role of epigenetics in shaping health outcomes How nutrition, stress, sleep, and lifestyle influence gene expression Why family patterns often reflect shared habits rather than destiny How positive thinking and emotional health affect inflammation and healing The importance of real food, movement, rest, and stress management How acupuncture and holistic care support healthy gene expression Shifting from a mindset of inevitability to empowerment   For full show notes, resources and links head to: https://vitalhealthcda.com/podcasts/   The Vital Health for You Podcast is for everyone. Get to know us more by connecting with us at our website or on our Facebook page.   *Disclaimer: The statements made in this episode about specific products have not been evaluated by the U.S. Food & Drug Administration and are not intended to diagnose, treat, cure or prevent disease. All information provided is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. 

Martín Bianchi repasa junto a Àngels Barceló como el rey emérito, Juan Carlos I, da fe de buena salud a través de las imágenes de sus visitas, pidiendo que "dejen de matarle". También comentamos los millones de libras que los padres del ex príncipe Andrés, Isabel II y Felipe de Edimburgo prestaron para silenciar a las supuestas victimas del caso Epstein en el que estaba inmerso su hijo, también prestó dinero Carlos III, su hermano y actual rey. 

Dr. Lauren Colenso-Semple, PhD, is an expert in the science of strength and muscle building and nutrition. She explains the most effective resistance and cardiovascular training programs for women and if and how those programs should differ from those followed by men. She explains program design options, exercise selection, sets, repetition ranges, rest periods, if you need to train to failure and much more. We discuss the relevance of menstrual cycles, (peri)menopause, birth control, body frame differences, as well as best practices for nutrition, hormone replacement and supplementation. Throughout the episode Dr. Lauren Colenso-Semple dispels common myths about women's fitness and nutrition such as the impact of fasting, cortisol, weight vests and more. This episode provides a masterclass in the best science-supported fitness and nutrition programs for women and for men. Thank you to our sponsors AG1: https://drinkag1.com/huberman Joovv: https://joovv.com/huberman Eight Sleep: https://eightsleep.com/huberman Rorra: https://rorra.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Lauren Colenso-Semple (00:02:43) Muscle in Men vs Women; Testosterone; Individual Variation (00:08:07) Sponsors: Joovv & Eight Sleep (00:10:45) Testosterone & Women; Resistance Training; Young Girls (00:17:46) Tool: Beginner Resistance Training for Women; Frequency & Goals (00:20:58) Tools: Weekly Full-Body Workouts, Work Sets, Rest Intervals; Time Efficiency (00:28:43) Forced Reps, Drop Sets; Rate of Movement; Partial Reps (00:33:19) Tool: Repetition Ranges; Technique; Vary Rep Ranges? (00:39:37) Sponsor: AG1 (00:40:28) High Reps & Injury, Technique & Warm-Ups (00:44:25) Cardiovascular Exercise, Interference Effect?; Walking, High Intensity (00:52:43) Menstrual Cycle, Hormones & Training; Overcoming Internal Resistance (00:56:54) Training & Body Composition; Tool: Slow Progression; Menstrual Cycle (01:02:45) Sponsor: Rorra (01:03:59) Hormone Contraception & Adaptations; Perimenopause, Menopause (01:09:01) Age-Related Muscle Loss, Nervous System, Tool: Machines & Group Fitness (01:14:57) Menstrual Cycle & Physical Activity; Nutrition (01:17:50) Pilates, Genes, Tool: Resistance Training to Offset Age-Related Muscle Loss (01:26:25) Ectomorph, Mesomorph or Endomorph? (01:28:55) Sponsor: Function (01:30:42) Train Fasted?, Caffeine, Preworkout & Postworkout Nutrition (01:38:29) Protein, Resistance Training & Timing (01:40:12) Creatine Supplements, Gummies, Dose, Brain Health Benefits? (01:45:44) Individual Experience; Skepticism & Science, Menopause & Body Composition (01:54:52) Cortisol & Women, Stress & Diet, Cushing Syndrome (02:00:17) Overtraining?, Sleep Disruptions, Energy & Training Time (02:04:07) Menopause Symptoms & Hormone Therapy, Testosterone (02:09:22) Women Differences in Diet & Training?; Exercise Science Studies (02:16:19) Lauren's Training Schedule, Mobility Work (02:19:35) Hormone Therapy & Long-Term Outcomes; Deliberate Cold Exposure (02:23:06) Zone 2 Cardio; Weighted Vest; Balance Training; Ab Exercises; Recovery (02:29:26) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

El envejecimiento ya no es inevitable… y la ciencia acaba de demostrarlo.En este episodio del podcast, Dr. Hernández, neurocirujano y divulgador científico, revela por qué estamos viviendo el inicio real de la revolución de la longevidad. A lo largo de la conversación se abordan los avances más impactantes en rejuvenecimiento celular, reprogramación genética, genes de la juventud, y el fin del envejecimiento como lo conocemos.Una conversación imprescindible sobre salud, ciencia, longevidad y futuro humano.

MMM is sponsored by 321 - a new online introduction to Christianity, presented by former MMM guest Glen Scrivener. Check it out for free at 321course.com/MMM. Just enter your email, choose a password and you're in — there's no spam and no fees. Give the gift of everyday luxury and make every moment comfortable. Head to cozyearth.com and use my code COZYMMM for 20% off sitewide. And if you get a Post-Purchase Survey, be sure to mention you heard about Cozy Earth at the Maiden Mother Matriarch podcast.Testing a foetus or an embryo for some medical conditions is now a routine part of the modern pregnancy experience. Prenatal Down's Syndrome tests, for instance, are now so widespread that in some Scandinavian countries almost 100 per cent of women choose to abort a foetus diagnosed with the condition, or – if using IVF – not implant the affected embryo. The result is a visible change to these populations: there are simply no more people with Down's to be seen on the streets of Iceland and Denmark.New technology is now available – at a high price – for those who want to go further. So-called polygenic embryo screening can give a very full picture of the adult that the embryo could become, including his or her vulnerability to an enormous number of diseases – heart disease, diabetes, cancer – and also the physical and psychological traits that he or she would likely possess: height, hair colour, athletic ability, conscientiousness, altruism, intelligence. Is this a good thing? Should we welcome a world in which parents are routinely selecting their embryos in this way? I'm joined today by two guests who take a very different view. Emma Waters is a policy analyst at the Center for Technology and the Human Person at the Heritage Foundation. Her work focuses on family, biotechnology, and reproductive medicine.Jonathan Anomaly is a philosopher, author of the book 'Creating Future People: The Science and Ethics of Genetic Enhancement', and is also the director of scientific research and communication for Herasight, a genetics startup that offers polygenic embryo screening. Hosted on Acast. See acast.com/privacy for more information.

El Arca de la Alianza ha infundido durante siglos un temor reverencial. Se decía que poseía poderes extraordinarios: hacer aparecer alimentos, derribar muros o comunicarse directamente con Dios. ¿Eran estos poderes realmente divinos, o quizá el Arca fue en realidad un artefacto de tecnología avanzada? Además, se afirma que otros objetos misteriosos, como el anillo de Salomón, tenían la capacidad de controlar fuerzas sobrenaturales. Un disco solar de origen inca podría haber sido un instrumento para comunicarse con reinos ignotos. De forma similar, a la enigmática calavera de cristal de los mayas se le atribuye la función de ser un antiguo dispositivo de almacenamiento de información. ¿Y si estos objetos legendarios nos ofrecieran pistas sobre la posibilidad de que las civilizaciones antiguas poseyeran conocimientos tecnológicos muy superiores a los que imaginamos? ¿Y si fueran, en realidad, poderosos dispositivos de un pasado extraterrestre ya olvidado?

La madre de la presentadora desapareció en mitad de la noche de su casa en Tucson, Arizona, y fue vista por última vez el 31 de enero.

Como organización global de certificación forestal que opera en paisajes forestales que incluyen territorios certificados de Pueblos Indígenas, el Forest Stewardship Council muestra su preocupación por la difusión de imágenes de los Mashco Piro, un pueblo indígena en aislamiento. Hablamos con Lorena Martínez, integrity manager de FSC. Escuchar audio

Devocional diario de Mons. Roberto Sipols para "La Voz de Jesús"Para información de nuestro ministerio y redes sociales, visita https://linktr.ee/lavozdejesus

Spring is right around the corner and as the weather changes and things begin to bloom, that also means the onset of allergy season. Last fall, we sat down with Tina Sindher who shared that while allergies may be affecting more people worldwide, prevention is playing catch up. If you're someone or know someone who lives with environmental or food allergies, we hope you'll tune into this episode to hear some of Tina's strategies for better managing these conditions.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Sayantani (Tina) SindherConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Tina Sindher, a professor of medicine and allergy at Stanford University.(00:01:50) Inside the Immune ResponseWhy our immune systems trigger allergic reactions.(00:03:31) Genes vs. EnvironmentWhether genetics or environment drive allergy risks.(00:06:39) The Microbiome FactorThe role of the microbiome and early exposures in prevention.(00:07:51) A Global Allergy SurgeHow global allergy trends reveal rising health challenges.(00:10:29) Potent Food TriggersWhy some foods cause stronger and faster reactions.(00:12:23) Emerging RisksWhether Alpha-Gal signals new emerging allergy risks.(00:14:21) Multi-Food AllergiesHow multi-food allergies complicate diagnosis and treatment.(00:17:36) Preventing Allergies EarlyWhy early food introduction may help prevent allergies.(00:19:28) Skin's Role in AllergiesThe importance of infant skin health in allergy development.(00:22:13) Testing LimitationsThe limits of current testing methods to truly diagnose allergies.(00:23:47) Standard Testing ProcedureThe current methodologies deployed when testing for allergies.(00:26:02) New TherapiesHow new therapies like OIT and Xolair are reshaping treatment.(00:30:24) The Future of AllergiesThe potential of combined therapies to aid in allergy treatment.(00:33:07) Managing Seasonal AllergiesHow to manage seasonal allergies effectively at home.(00:35:41) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

-11F Día de la mujer y la niña en ciencia (07:00) -Titular en La Vanguardia:“El logro de Barbacid es una mala noticia para la ciencia” (15:00) -Depredadores jurásicos, devoradores de bebés (22:00) -Sag A* como materia oscura en vez de agujero negro (44:00)

-Sag A* como materia oscura en vez de agujero negro (00:00) -11F Día de la mujer y la niña en ciencia (36:00) -Mapa genético de desórdenes psiquiátricos (1:05:00) -AlphaGenome de DeepMind promete revolucionar la medicina (1:21:00) -Vacunas origami de ADN (1:48:00)

Howie and Harlan are joined by geneticist and endocrinologist Joel Hirschhorn to discuss how thousands of genetic variants collectively shape disease and traits like height and obesity. Harlan reviews new research on diet soda and dementia; Howie surveys recent market swings, including the rise of Solace Health and the decline of Hims & Hers. Show notes: Diet Soda and Dementia "Soda consumption and risk of dementia: The Northern Manhattan study"  "Why One Cardiologist Has Drunk His Last Diet Soda" Joel Hirschhorn National Human Genome Research Institute: Mendelian Inheritance MedlinePlus: FGFR3 gene  Cleveland Clinic: Achondroplasia National Human Genome Research: Polygenic Trait  Hirschhorn Lab "A saturated map of common genetic variants associated with human height"  "What are single nucleotide polymorphisms (SNPs)?" ScienceDirect: Genetic Variant Joel Hirschhorn: "Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci" Joel Hirschhorn: "Polygenic prediction of body mass index and obesity through the life course and across ancestries" "Obesity Prediction Could Be Guided by Genetic Risk Scores" "Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia"  Society for Science: Noam Elkies MIT: Eric S. Lander Ups and Downs "Understanding Creative Destruction: Driving Innovation and Economic Change" "Solace Health raises $130M series C for advocacy platform" "Molina Healthcare's stocks fall as company plans exit from Medicare Advantage"  "Centene swings to loss but predicts stabilization in 2026" "UnitedHealth limps into 2026 with a smaller business and fresh challenges" "Hims & Hers Falls 14% After Pulling Copycat Wegovy Pill—Novo Nordisk Up 8%"  "Compounding and the FDA: Questions and Answers" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Con Andalucía presente todo el rato. Todo el rato acordándose de los andaluces. Porque aquellos días en Catarroja fueron terribles. Porque el agua con furia es un enemigo que cruza territorios sin entender de fronteras ni lindes.Aquellos días en los que Mayte luchaba por poner en pie de nuevo su peluquería, arrasada por la Dana, recibió mucha ayuda. Y eso no se olvida. Así que, ahora, quiere devolver lo que pueda. Su local se ha convertido en un almacén improvisado para enviar cosas de primera necesidad a Andalucía.Es Mónica, la hermana de Mayte Fortea. Mañana viernes sale ese enorme furgón para Cádiz, donde estos días, mientras lavan cabezas, están las suyas.Hasta el último instante, antes de que salga la comitiva, se puede llevar de todo. Muebles, ropa, productos de limpieza. Porque Mónica todavía recuerda lo mal que se pasa, la angustia que se vive.Qué fácil lo hace la gente, ¿verdad? Devolver lo que se recibió y no olvidar. La cadena de favores de ...

  Genes. Glands. Vessels.

 What if a baby's wobbly reach for a spoon or a make-believe tea party could quietly change the way language unfolds? In this episode of Mind The Kids, “Building Blocks: How motor and social skills shape language learning, as captured by genes” host Mark Tebbs talks with Dr Beate St Pourcain and Dr Ellen Verhoeff from the Max Planck Institute for Psycholinguistics about what it really means to develop language in a developing body.Drawing on their JCPP study of over 6,000 children in the ALSPAC cohort, they follow a developmental cascade that starts with early gross motor milestones like sitting and crawling, moves through culturally shaped self-care and pretend-play skills like using a spoon or hosting a tea party, and then flows into vocabulary and grammar between 15 and 38 months. Along the way, they unpack how genetics and environment intertwine, why social interactions and playful routines act as gateways into language rather than just nice “add-ons,” and what this might mean for parents, carers, clinicians and educators who want to support communication in both autistic and non-autistic children. You can read the main JCPP paper discussed in this episode, “Developing language in a developing body: genetic associations of infant gross motor behaviour and self-care/symbolic actions with emerging language abilities” via https://doi.org/10.1111/jcpp.70021 Get a free CPD/CME certificate for listening to this podcast by registering for a FREE ACAMH Learn account at https://www.acamhlearn.org Visit https://www.acamh.org Facebook and LinkedIn search / ACAMH Instagram https://www.instagram.com/assoc.camh Bluesky https://bsky.app/profile/acamh.bsky.social X https://x.com/acamh 

Free Webinar - Wednesday February 11 - https://www.hackmydna.com/sarah Previous episode with Kash on HRT - https://www.youtube.com/watch?v=7Jaa_kjm-K0Blueprint Live Program - Waitlist - https://www.sarahkleinerwellness.com/the-bio-individual-blueprint-waitlistBlueprint OnDemand (get access now & get a custom protocol) - https://www.sarahkleinerwellness.com/offers/2oECuhhC/checkout?coupon_code=ONDEMANDSauna Article - understanding protocols - timing - when binders are OK and when to skip & how to support your detox pathways - https://open.substack.com/pub/sarahkleinerwellness/p/binder-with-your-sauna-not-so-fast?utm_campaign=post-expanded-share&utm_medium=webTanning Bed Article - the lost science of UV light & why all tanning beds and light therapy isn't the same - https://sarahkleinerwellness.substack.com/p/tanning-beds-uv-light-and-the-lostFertility Signals Bundle with Deuterium Protocol - https://www.sarahkleinerwellness.com/offers/NUzm6KoY/checkout?coupon_code=RMDYDeuterium only course - https://www.sarahkleinerwellness.com/offers/Qj8as8ep/checkout21 Day Leptin Reset (click here for my most foundational program) - https://www.sarahkleinerwellness.com/offers/NNFJ5zEi/checkoutLeptin Resistance Quiz (click here to take the free quiz) - https://www.sarahkleinerwellness.com/21dayleptinquestionaire_________Sponsored By:→ VivaRays | This episode is sponsored by VivaRays - VivaRays Blue - code YOGI https://vivarays.com/yogi→ Troscriptions | For an exclusive offer, go to https://www.troscriptions.com/SARAHK for 10% off your first non subscription order._________Timestamps:00:00 Introduction and Podcast Overview01:25 Early Access and Special Offers on Substack03:27 Personal Challenges and Real-Life Struggles05:34 Gene Testing and Mitochondrial Health12:21 Menopause, Hormones, and Light Therapy14:35 Nervous System Support and Stabilization16:56 Sauna Protocols and UVB Light Therapy21:48 Methylene Blue and Supplementation23:26 Blue Blockers and Circadian Rhythm25:12 Understanding Low Leptin and Weight Loss25:28 Repletion Protocol for Low Leptin25:59 Mineral Loading and System Repletion26:36 Addressing Circadian Rhythms and Stress27:01 Balancing Carbs and Blood Sugar27:11 Personalized Protocols and Blueprint Program29:09 Fertility in Your Forties30:35 Deuterium Depletion and Mitochondrial Health36:00 Light Environment and Mitochondrial Function43:09 Histamine Intolerance and Liver Support45:43 Final Thoughts and Resources——— This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________Get all my free guides and product recommendations to get started on your journey!https://www.sarahkleinerwellness.com/all-free-resourcesCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) -  https://www.sarahkleinerwellness.com/coursesMy free product guide with all product recommendations and discount codes:https://www.canva.com/design/DAF7mlgZpJI/xVyE4tiQFEWJmh_Xwx8Kbw/view?utm_content=DAF7mlgZpJIFree Webinar on Light & Health (includes free light bulb guide) - https://www.sarahkleinerwellness.com/mycircadianapp-free-webinarGet Early Access to Podcast Episodes & my Seasonal Food Course + UVB+Red Light Therapy course for free -  https://open.substack.com/pub/sarahkleinerwellness/p/uvbred-light-protocol?r=5eztl9&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

[This episode originally aired on April 18, 2023] Buddhists are always talking about awakening, but what does that actually mean?  •  Trungpa Rinpoche taught that what is being awakened are our "enlightened genes" — a term which implies that awakening is somewhat natural, somewhat part of our makeup  •  sometimes Tibetans use the analogy of an acorn: if you try to get an oak tree by planting a bean seed, it will never work; but if you plant an acorn, you get an oak tree, not anything else  •  in the same way when you plant a human, you end up with an awakened being  •  there are two traditional signs that our enlightened genes are awakening: the first is that we become more kind; the second is that we become less deceptive  •  there are also two traditional signs that indicate our enlightened genes are not being awakened: the first is being unable to react to suffering; and the second is having a kind of a pettiness of mind  •  so if you really want to look for signs of progress on the path, don't look so much for how much you've learned, how clever you are, how many hours of sitting you've done  •  in this teaching it's said to look for simple things: your level of kindness, your level of straightforwardness and truthfulness, your ability to react to suffering, and your willingness to extend your vision further.

Dr. Kathryn Paige Harden, PhD, is a psychologist, behavioral geneticist and professor of psychology at the University of Texas at Austin. We discuss how genes interact with your upbringing to shape your level of risk-taking and morality. We also discuss how genes shape propensity for addiction and impulsivity in males versus females. Finally, we discuss how biology impacts societal views of sinning, punishment and forgiveness. Read the episode show notes at hubermanlab.com. Pre-order Protocols: https://go.hubermanlab.com/protocols Thank you to our sponsors AG1: https://drinkag1.com/huberman BetterHelp: https://betterhelp.com/huberman Lingo: https://hellolingo.com/huberman Our Place: https://fromourplace.com/huberman Helix Sleep: https://helixsleep.com/huberman Timestamps (00:00:00) Kathryn Paige Harden (00:03:10) Adolescents, Genes & Life Trajectory; Adolescence Ages (00:06:44) Puberty, Aging & Differences; Epigenome; Cognition (00:14:05) Sponsors: BetterHelp & Lingo (00:16:45) Puberty Onset & Family; Communication & Empathy (00:22:26) 7 Deadly Sins, Substance Use & Conduct Disorders, Genes (00:27:33) Family History; Genes & Brain Development (00:33:05) Personality & Temperament, Motivation, Addiction; Trauma (00:37:59) Knowing Genetic Risk & Outcomes; Understanding Family History (00:46:06) Sponsor: AG1 (00:46:57) Genetic Information & Decision Making; Personal Identity & Uncovering Family (00:52:12) Nature vs Nurture, Bad Genes?; Aggression, Childhood & Males (01:00:17) The Original Sin; Whitman Case & Brain Tumor; Genetic Predisposition (01:10:31) Free Will; Genes & Moral Judgement; Skillful Care for Kids; Social Cooperation (01:21:03) Breaking the Cycle; Genetic Recombination & Differences; Identity (01:25:21) Sponsor: Our Place (01:27:01) Status, Dominance, Science; Positive Attributes of Negative Traits (01:36:15) Relational Aggression & Girls; Male-Female Differences & Conflict (01:40:36) Genes, Boys vs Girls, Impulse Control (01:45:00) Behavior Punishment vs Rewards, Responsibility (01:51:29) Sponsor: Helix Sleep (01:53:03) Accountability; Suffering, Cancel Culture & Punishment (02:00:01) Life Energy & Punishment, Prison (02:08:16) Backward vs Forward-Looking Justice; Forgiveness, Retribution, Power, Choice (02:16:11) Reward, Unfairness & Inequality (02:21:59) Punishment, Reward & Power; Online vs In-Person Communities (02:29:49) Identical Twin Differences; Genetic Influence & Age; Sunlight & Genes (02:39:24) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

 In this powerful episode, Dr. Vaughn & Dr. Joshua discuss genetics vs. terrain. What if your “genetic” illness is really inherited toxicity?- Why environment, terrain, and toxins matter more than your genes- How glyphosate, farm chemicals, and vaccines impact the gut, collagen, and immune system- The difference between symptom management and true healing & restoration- A biblical perspective on health, stewardship of the body, and spiritual warfare in medicinePRACTICAL FIRST STEPS TO HEAL:Clean up your diet (whole foods, fewer processed foods and seed oils)Get sunshine, movement, and fresh airUse key supplements (minerals, vitamins, glutathione, binders, probiotics)How to start detoxing kids and families safely and support vaccine-injured or toxic kidsWhy involving the whole family in lifestyle change leads to generational blessing To find out how we can help you on your health journey, book a free 15-minute Discovery Call with one of our New Client Coordinators! Click the link: https://www.spiritofhealthkc.com/discoverycall For more health tips and information visit: https://www.spiritofhealthkc.com/To buy natural health supplements visit: http://store.spiritofhealthkc.com Facebook: https://www.facebook.com/SpiritofHealth/ Instagram: https://www.instagram.com/spiritofhealthkc/ Pinterest: https://www.pinterest.com/spiritofhealthkc/YouTube: https://www.youtube.com/channel/UCwRcNSxR3kMYi9wP8OmxlQQ Spotify: https://open.spotify.com/show/7yfBBUjWKk3yJ3auK71O7H?si=295c77ed21f14568&nd=1&dlsi=af01c00121ed4aed

Defining brain cell types is no longer a matter of classification alone, but of embedding their genetic identities within the dynamical organization of population activity.

Monumentos como Stonehenge, Newgrange o las pirámides de Guiza, muestran asombrosos alineamientos celestes que difícilmente pueden ser una mera coincidencia. ¿Cuál era exactamente su propósito?

Welcome! and Thank you for listening.  Lp(a) is a genetic marker associated with increased cardiovascular events.  A positive family history is also associated with increase risk.  But how much risk and over what time period.  Families share the same cultures, living environment and often food choices but not always.  Genes don't act alone.  They need the right stimulus or environment to become activated.   There is no one that knows your story better than you.  Yet, one cannot predict their own future with any degree of certainty.  The story always unfolds a little different.  To think a physician can predict ones future is also a bit of a long shot.  Heart disease is the number one killer in America with cancer being number two.  The odds are pretty high that one of those illnesses may cross your door.  The question is which and when.  I believe we are in control of our destiny more than our genes or family history.   How heart disease or other illnesses affect our lives is guided by lifestyle choices and beliefs.  Being healthy is a choice.  Being healthy is a choice.  You just need to BELIEVE.  To understand more take a listen.  Thank you as always.  If you would like help attaining your health goals, check out our website at doctordulaney.com Email me at Jami@doctordulaney.com Lp(a) and risk of cardiovascular disease: https://cdn.jamanetwork.com/ama/content_public/journal/cardiology/0/hoi250076f3_1766513579.95844.png?Expires=1773391267&Signature=UtIeIN2lwyYBtOwRfwxf4FeK-dokS3u3bhcUEL9u3cLdpTWBlp9bQyjL0jc-Gnhz8qdagEMNIpkhSHhx2TwJ8HUHlZ6pQtWEKYAiLtGzMz3vNtRXmRtfXHAba~LXFvT3TMM6smZluqippWMYrBMnojWe1mil6BuLUPyHHQLpliLEctMqPzOJkJnWj5lYil~QHmJHE3Rl7VNU5WMPdC79dD66s9DUl-8--pUiuREuAcAZcj74gOzkPHQekYYynHBXuNVjhzGNe34Z4z21gGE4siE46V~I~ycerWXGG1eVom3xTtxneIlxpDQ2J6HdY3t6F2J9jW3cc4241WRw52NyJA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA Plant based wellness cookbook: amzn.to/4onHVe4 Water distillers: mypurewater.come?sld-jdulaney.  discount code: cleanwaterforsophie Believe: Dr Kevin Elko -sports psychologist 

Hoy subimos a los palacios del genio renacentista y bajamos a las calles devastadas por la crisis de opioides, porque en DÍAS EXTRAÑOS nada de lo humano nos es ajeno. Pablo Fuente nos trae tres historias que parecen ciencia ficción pero son ciencia pura y dura: científicos extraen el ADN de Leonardo da Vinci de un dibujo de 500 años usando un simple bastoncillo de algodón, y lo comparan con 14 descendientes vivos para confirmar el código genético del genio. Luego descubrimos cómo una inteligencia artificial llamada Sleep FM analiza tus noches de sueño y predice enfermedades que desarrollarás dentro de 5 o 10 años, antes de que aparezca el primer síntoma. Y cerramos con un giro inesperado en la devastadora crisis del fentanilo en Estados Unidos: las muertes han caído un 15% y nadie lo vio venir... excepto Reddit. Sí, la red social detectó la "sequía" del opioide meses antes que los datos oficiales, revelando cómo la diplomacia entre Biden y Xi Jinping cortó la cadena de suministro desde China. Tres historias que demuestran que la ciencia puede leer el pasado en una célula, el futuro en un sueño y el presente en un foro de internet. Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

The latest episode of Busy Body Podcast featuring conversation with Journalist and co-Author of the book Food Intelligence, Julia Belluz is out now. It's a super informative conversation and a really great book. (order here) Busy Body is now on Patreon! If you've been a long time listener, please consider supporting the pod! Your support will help me be able to put more episodes out more regularly. If just twenty people joined the 2nd tier we'd have an extra episode a month covered! The audio version of the podcast will continue here on Substack, you can also upgrade to paid and support the pod and my writing here. Truly anything helps. Subscribe now If you are more of a here-for-the-pod person, on Patreon, we're offering an ad-free video tier, a gift-in-the-mail tier and an UNFILTERED tier where members get access to bonus content conversations as well as mini segments from me on topical subjects and my (strong) opinion on them - if that tier takes off, I can open the private chat option so we can all chat with each other! Thank you for listening! I'm hoping this move will help me better understand and get to know my listeners and better understand and get to know my Substack readers! These communities are growing and are distinct - I so appreciate you and hope you'll join me wherever is best for you! Now onto the show!   I've been following Julia Belluz's writing for awhile and when I heard she was putting out a book co-authored with Kevin Hall PhD I literally pre-ordered it twice (accidentally but still!).  Food Intelligence did not disappoint! We cover a lot in this conversation from 'food environments' to the unrelegated world of supplements, and of course the discourse around 'obesity', fat bodies and health. It's a great conversation and I also hope to have Kevin Hall on soon so stay tuned! You can buy Food Intelligence HERE Follow Julia HERE And find more about her and her work HERE Please take a moment to like, share, comment or rate and review this podcast wherever you are listening to it! Doing any of those things help more people to find this pod! Music by Rob Byrne, performed by the Wild Yaks. Podcast produced by Brad Parsons at Trains Sound Studio. Illustration Azul Trejo.

In this episode, we talk with Dr. Gary Miller, a professor at Columbia University, about how the air we breathe, the water we drink, and the products we use every day may be shaping our health more than our genes ever could. We dive into the science of the “exposome,” why diseases like Parkinson's and obesity are rising so fast, and what everyday chemicals might be doing inside your body. Along the way, we get practical about what actually matters — from water filters and air purifiers to plastics, perfumes, and even flowers on cakes. Dr. Miller breaks down what's truly worth worrying about and what's not. If you've ever wondered how much control you really have over your environment (and your future health), this episode will change how you look at everything around you.Sign up for our newsletter here!For weekly episodes, come join the Foodie Fam!Check out our book!Chat with us on IG @foodweneedtotalk!Be friends with Juna on Instagram and Tiktok! Learn about your ad choices: dovetail.prx.org/ad-choices

Save your seat: https://www.hackmydna.com/sarahIn this episode of the Evolving Wellness Podcast, host Sarah and her guest Cash discuss the complexities of personalized health strategies, focusing on genetic variability and its impact on diet, hormones, and therapies like peptides and red light therapy. They explore the differences in how individuals react to ketogenic diets, the role of specific genes like APO A2 and TCF 7L2 in metabolic health, and the nuances of using biohacking tools such as NAD and glutathione. They emphasize the importance of understanding genetic profiles for effective and safe health interventions. Sarah announces an upcoming free webinar for deeper dives into these topics and audience Q&A. The episode underlines the necessity of a bio-individual approach for optimal wellness.About Hack My DNA's Mission: Hack My DNA is focused on helping people understand and optimize their health by using their unique genetic blueprint. Founded by Sarah, the platform bridges the gap between raw DNA data and real-life action—translating genetic insights into practical strategies for nutrition, lifestyle, and long-term wellness. Hack My DNA's mission is to empower individuals to make informed, personalized health decisions by uncovering how their genes influence everything from metabolism and detoxification to inflammation and aging, so they can live healthier, more intentional lives_________Sponsored By:→ VivaRays | This episode is sponsored by VivaRays - VivaRays Blue - code YOGI https://vivarays.com/→ Troscriptions | For an exclusive offer, go to https://www.troscriptions.com/SARAHK for 10% off your first non subscription order._________Timestamp:00:00 Introduction to Ketogenic Diet and Genetics01:04 The Role of Genes in Diet and Health01:43 Webinar Announcement and Guest Introduction04:18 Understanding MTHFR and Methylation05:56 Methylation's Impact on Health09:19 Genetic Variability in Health Responses15:08 Cold Therapy and Genetic Differences23:20 Hormone Replacement and Genetic Considerations29:21 Debating Hormone Therapy30:16 The Importance of Individualized Health31:21 Understanding Genetic Blocks32:28 Exploring Peptides33:30 The NAD Debate36:13 Genetic Variability in Peptide Response43:09 Red Light Therapy Insights53:23 Join Our Live Webinar——— This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________Get all my free guides and product recommendations to get started on your journey!https://www.sarahkleinerwellness.com/all-free-resourcesCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) - https://www.sarahkleinerwellness.com/coursesMy free product guide with all product recommendations and discount codes:https://www.canva.com/design/DAF7mlgZpJI/xVyE4tiQFEWJmh_Xwx8Kbw/view?utm_content=DAF7mlgZpJIFree Webinar on Light & Health (includes free light bulb guide) - https://www.sarahkleinerwellness.com/mycircadianapp-free-webinarGet Early Access to Podcast Episodes & my Seasonal Food Course + UVB+Red Light Therapy course for free - https://open.substack.com/pub/sarahkleinerwellness/p/uvbred-light-protocol?r=5eztl9&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

After five years, Levitt is ending People I (Mostly) Admire, and will start hosting the occasional Freakonomics Radio episode. We couldn't be happier. SOURCES:Steve Levitt, co-author of Freakonomics and host of People I (Mostly) Admire. RESOURCES:"How to Help Kids Succeed," by People I (Mostly) Admire (2025)."Feeling Sound and Hearing Color," by People I (Mostly) Admire (2024)."Richard Dawkins on God, Genes, and Murderous Baby Cuckoos," by People I (Mostly) Admire (2024)."Arnold Schwarzenegger Has Some Advice for You," by People I (Mostly) Admire (2024)."Drawing from Life (and Death)," by People I (Mostly) Admire (2023)."Yuval Noah Harari Thinks Life is Meaningless and Amazing," by People I (Mostly) Admire (2022)."Is This the Future of High School?," by People I (Mostly) Admire (2022)."Does Death Have to Be a Death Sentence?," by People I (Mostly) Admire (2022)."Sal Khan: 'If It Works for 15 Cousins, It Could Work for a Billion People.'" by People I (Mostly) Admire (2021)."Jared Diamond on the Downfall of Civilizations — and His Optimism for Ours," by People I (Mostly) Admire (2021)."Amanda & Lily Levitt Share What It's Like to be Steve's Daughters," by People I (Mostly) Admire (2021)."How Rahm Emanuel Would Run the World," by Freakonomics Radio (2020).The Levitt Lab. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Genomics researcher Dr. Robert Green explains how sequencing babies' DNA can reveal hidden health risks. This hour we explore where the benefits end and the ethical dilemmas begin.Guests include Dr. Robert Green, bioethicist and pediatrician Dr. Lainie Friedman Ross and genetic counselor Bethany Zettler.TED Radio Hour+ subscribers now get access to bonus episodes, with more ideas from TED speakers and a behind the scenes look with our producers. A Plus subscription also lets you listen to regular episodes (like this one!) without sponsors. Sign-up at plus.npr.org/ted.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy